N-Zyme Biomedical
PrivateLast Round
Series A
Jul 22, 2026
Total Funding Raised
$4.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
N-Zyme Biomedical is a clinical-stage biotechnology company developing first-in-class therapies targeting pepsin to treat laryngopharyngeal reflux and gastroesophageal reflux disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
N-Zyme Biomedical Comparables
Compare N-Zyme Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ellodi Pharmaceuticals | 68% | |
| Phathom Pharmaceuticals | 66% | |
| ThirtyFiveBio | 60% |
N-Zyme Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 22, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 76% MoM, reaching 4.8K.
- Jul 22, 2026
$5M round completed.
N-Zyme Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about N-Zyme Biomedical's valuation, stock price, and market status.
Is N-Zyme Biomedical a public or private company?
N-Zyme Biomedical is a private company.
What is the current stock price of N-Zyme Biomedical?
N-Zyme Biomedical is a private company with no public stock price. Caplight tracks N-Zyme Biomedical's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is N-Zyme Biomedical worth (valuation)?
Valuation information for N-Zyme Biomedical is not publicly available.
Can I buy N-Zyme Biomedical stock?
N-Zyme Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was N-Zyme Biomedical's last funding round?
N-Zyme Biomedical's most recent funding round was Series A on July 22, 2026.
Who are the main investors in N-Zyme Biomedical?
Investor information for N-Zyme Biomedical is not publicly disclosed.
Will N-Zyme Biomedical IPO soon?
No public IPO plans have been announced for N-Zyme Biomedical.
How can I track N-Zyme Biomedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor N-Zyme Biomedical's secondary market activity and sign up for updates.